All In MedTech

Device Trial Radar · NCT00448006

Clinical Feasibility Study of Allium's Biliary Stent

A Clinical Feasibility Study to Evaluate the New Allium Biliary Stent, in Patients Suffering From "Malignant Biliary Duct Obstruction" (Endoscopic Insertion)

Last checked: Nov 20, 2026Latest source record: Jul 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Apr 2008

Primary completion

Aug 2009

Sponsor

Lead sponsor
Allium, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Mar 15, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of the Allium Biliary Stent in malignant obstructions of the common bile duct.

Conditions

  • Malignant Obstruction of the Common Bile Duct

Interventions

  • Allium Biliary StentDevice

    device

  • allium biliary stentDevice

    allium biliary stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Body temperature measurement, patient comfort analysis, sonographic measurements of the duct channels, abdominal X-ray imaging of the stent, and blood tests will be performed at 24 hours, 30 days, 3, 6, and 12 months following stent insertion.Time frame: up to 12 months follow up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sheba Medical Center

    Ramat Gan, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.